Savoxepin
Alternative Names: CGP 19486; CGP 19486A; Cipazoxapine; SavoxepineLatest Information Update: 15 Jun 1998
At a glance
- Originator Novartis
- Class Antidementias; Antipsychotics; Neuroprotectants
- Mechanism of Action Dopamine D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 15 Jun 1998 Discontinued-II for Psychotic disorders in European Union (PO)